Search Results

Showing results 1891 - 1900 for weill cornell connect patient portal

Enhancing the Therapeutic Potential of mTOR Inhibitors in Breast Cancer: Overcoming Therapy Resistance in TNBC | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-and-partners/collaboration-opportunities/enhancing-therapeutic-potential-mtor

Identification and Development of Novel Antifungal Drugs for Treatment of Gastrointestinal Fungal Infections | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-and-partners/collaboration-opportunities/identification-and-development-novel

Development of A Novel Multi-functional Compound for the Treatment of Autoimmune Disorders | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-and-partners/collaboration-opportunities/development-novel-multi-functional

Developing Novel First-in-Class Therapeutics for Colorectal Cancer | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-and-partners/collaboration-opportunities/developing-novel-first-class

3-phosphoglycerate Dehydrogenase (PHGDH) Inhibitors | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/3-phosphoglycerate-dehydrogenase-phgdh-inhibitors

VEGF for the Treatment of Peripheral Nerve Damage | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/vegf-treatment-peripheral-nerve-damage

Automated Intracytoplasmic Sperm Injection Device | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/automated-intracytoplasmic-sperm-injection-device

Reagents and Methods for Assaying Protein Synthesis and Amino Acid Transport | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/reagents-and-methods-assaying-protein-synthesis-and

Selective Inhibition of ERK2 for Persistent Inflammatory and Neuropathic Pain | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/selective-inhibition-erk2-persistent-inflammatory

Intraocular Lens Design | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/intraocular-lens-design

Showing results 1891 - 1900 for weill cornell connect patient portal